Andrew Wright - Hemogenyx Pharmaceuticals Financial Sec
| HOPHF Stock | USD 0.04 0.00 0.00% |
Insider
Andrew Wright is Financial Sec of Hemogenyx Pharmaceuticals Plc
| Phone | 44 79 0917 7311 |
| Web | https://www.hemogenyx.com |
Hemogenyx Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (0.1771) % which means that it has lost $0.1771 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3235) %, meaning that it generated substantial loss on money invested by shareholders. Hemogenyx Pharmaceuticals' management efficiency ratios could be used to measure how well Hemogenyx Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Brian Sullivan | Elevation Oncology | N/A | |
| Stephen Elledge | Tscan Therapeutics | N/A | |
| Ibrahim MD | Enveric Biosciences | 55 | |
| RPh PharmD | Elevation Oncology | 40 | |
| Peter Facchini | Enveric Biosciences | 60 | |
| Tomasz Kula | Tscan Therapeutics | N/A | |
| Thomas Schaible | Fortress Biotech Pref | N/A | |
| David Dornan | Elevation Oncology | 46 | |
| Brian JD | Tscan Therapeutics | 55 | |
| Robyn Hunter | Mustang Bio | 62 | |
| William MBA | Tscan Therapeutics | 54 | |
| MBA IV | Enveric Biosciences | 68 | |
| Michael Esq | Fortress Biotech Pref | 57 | |
| Avani Kanubaddi | Enveric Biosciences | 51 | |
| Sharon McBrayer | Palisade Bio | N/A | |
| Gavin MacBeath | Tscan Therapeutics | 54 | |
| Joseph Ferra | Elevation Oncology | 49 | |
| CPA MBA | Kodiak Sciences | 60 | |
| Gerald Proehl | Dermata Therapeutics | 65 | |
| MD FAAAAI | Palisade Bio | N/A | |
| Ray Lockard | Tscan Therapeutics | N/A | |
Management Performance
| Return On Equity | -0.32 | |||
| Return On Asset | -0.18 |
Hemogenyx Pharmaceuticals Leadership Team
Elected by the shareholders, the Hemogenyx Pharmaceuticals' board of directors comprises two types of representatives: Hemogenyx Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hemogenyx. The board's role is to monitor Hemogenyx Pharmaceuticals' management team and ensure that shareholders' interests are well served. Hemogenyx Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hemogenyx Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Vladislav Sandler, CEO CoFounder | ||
| Alexis JD, Independent Director | ||
| Koen MD, Clinical Director | ||
| Andrew Wright, Financial Sec |
Hemogenyx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Hemogenyx Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.32 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | 8.17 M | |||
| Shares Outstanding | 1.14 B | |||
| Shares Owned By Insiders | 13.01 % | |||
| Price To Book | 1.78 X | |||
| EBITDA | (2.39 M) | |||
| Net Income | (5.1 M) | |||
| Cash And Equivalents | 6.84 M | |||
| Cash Per Share | 0.01 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hemogenyx Pharmaceuticals Plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Hemogenyx Pharmaceuticals information on this page should be used as a complementary analysis to other Hemogenyx Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Hemogenyx Pink Sheet analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |